UVM Receives $16.5 Million Grant to Fund Vermont Genetics Network
News Mar 10, 2006
The National Center for Research Resources (NCRR) at the National Institutes of Health has awarded a $16.5 million grant to the University of Vermont and Judith Van Houten, George H. Perkins Professor of Biology and the grant’s principal investigator, to fund a state-wide program called the Vermont Genetics Network (VGN).
U.S. Senator Patrick Leahy praised the award and application, saying, "This grant illustrates the vitality of UVM’s forward-thinking approach to research and development."
"Because the University has wisely adopted a collaborative approach to this work, Vermont’s status as a leader in biomedical research will truly be a state-wide effort."
UVM President Daniel Mark Fogel added, "We have done a good deal of thinking about what it means to be a 21st century land grant institution, and VGN provides just the kind of services and outreach we feel UVM should be offering Vermont and Vermonters in the new millennium."
"Through the VGN’s multi-faceted programs, in concert with our partner undergraduate institutions, we're having a significant impact on genetic research and science education in Vermont which, in turn, will benefit workforce development and job creation in the state."
"The VGN grant benefits Vermont through its support of the baccalaureate institutions that play crucial roles in our higher education and workforce development, its creation of facilities at UVM and our partner institutions," said Van Houten.
"The grant also enhances overall resources for biomedical research, which is key to many aspects of economic prosperity."
"Bringing the capability of doing advanced biomedical research to undergraduates throughout the state is a key element of VGN," added Van Houten.
"There’s a good chance that, by exposing these young people to the challenge and excitement of this work, they’ll be persuaded to continue with their studies and to become part of a highly skilled workforce in the state."
‘Good Cholesterol’ May Not Always be Good for Postmenopausal WomenNews
Postmenopausal factors may have an impact on the heart-protective qualities of high-density lipoproteins (HDL) – also known as ‘good cholesterol’ – according to a study led by researchers in the University of Pittsburgh Graduate School of Public Health.READ MORE
What Makes Good Brain Proteins Turn Bad?News
The protein FUS is implicated in two neurodegenerative diseases: amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Using a newly developed fruit fly model, researchers have zoomed in on the protein structure of FUS to gain more insight into how it causes neuronal toxicity and disease.